Frataxin depletion leads to decreased soma size and activation of AMPK metabolic pathway in dorsal root ganglia sensory neurons
Abstract
Introduction
Friedreich’s ataxia (FA) is an inherited neurodegenerative disorder caused by frataxin deficiency, leading to impaired iron–sulfur (Fe–S) cluster biogenesis and mitochondrial dysfunction. Proprioceptive dorsal root ganglia (DRG) neurons are among the most vulnerable cell types in FA, yet the mechanisms underlying their selective susceptibility remain unclear.
Methods
We developed a primary culture model of embryonic mouse DRG neurons with complete frataxin depletion, enabling longitudinal analysis of cellular and metabolic alterations.
Results
This novel model reproduces several key biochemical hallmarks of FA, including Fe–S enzyme deficiency, mitochondrial dysfunction, altered iron homeostasis and oxidative stress. Despite severe mitochondrial impairment, frataxin-deficient neurons remained viable but exhibited a marked reduction in soma growth. Mechanistically, this phenotype was associated with activation of AMP-activated protein kinase (AMPK) hyperactivation and inhibition of mTOR signaling. Genetics inhibition of AMPK or re-expression of frataxin restored neuronal growth, demonstrating a functional link between metabolic stress signaling and soma size regulation. Treatment with α-lipoic acid (ALA) rescued soma growth, normalize ATP levels and reduce AMPK activation.
Conclusions
Our findings identify AMPK–mTOR signaling as a key pathway linking mitochondrial dysfunction to impaired neuronal growth impairment in frataxin-deficient sensory neurons. This robust, scalable cellular model provides new insights into sensory neuron vulnerability and offers a platform for therapeutic discovery.
Related articles
Related articles are currently not available for this article.